Interest in the work of Spanish researcher López Bran aimed at putting an end to baldness has reached India.

Research into a new therapy based on the use of stem cells to treat the most common type of baldness—caused by genetic factors—has been one of the main highlights of the FUE ASIA congress, held in India from last Friday through Monday. The principal investigator of the AGACell project, Dr. Eduardo López Bran, participated in the congress as one of the guests of honor, where he delivered a lecture presenting his methodology, the current status of the research, and the results he expects to achieve.

“Androgenetic alopecia (AGA) can be reversed with cell therapy.” This is demonstrated by the successful results of the research I lead at the San Carlos University Clinical Hospital in Madrid,” said the head of the hospital’s Dermatology Department and director of the specialized IMEMA clinic, as reported to EFE Salud.

Held in the Indian city of Hyderabad, FUE ASIA is considered the world’s most important global meeting of medical specialists dedicated to combating hair loss, bringing together around 700 medical and academic representatives from more than 20 countries across Asia, North America, Ibero-America, and Europe.